APA (7th ed.) Citation

M, D., A, K., F, B., G, O., M, R., C, P., . . . X, C. (2026). Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors. Transplant international : official journal of the European Society for Organ Transplantation, 39, 15318. https://doi.org/10.3389/ti.2026.15318

Chicago Style (17th ed.) Citation

M, Deslais, et al. "Comparable Outcomes with Anti-thymocyte Globulins Versus Basiliximab in Kidney Transplantation from Controlled Circulatory Death Donors." Transplant International : Official Journal of the European Society for Organ Transplantation 39 (2026): 15318. https://doi.org/10.3389/ti.2026.15318.

MLA (9th ed.) Citation

M, Deslais, et al. "Comparable Outcomes with Anti-thymocyte Globulins Versus Basiliximab in Kidney Transplantation from Controlled Circulatory Death Donors." Transplant International : Official Journal of the European Society for Organ Transplantation, vol. 39, 2026, p. 15318, https://doi.org/10.3389/ti.2026.15318.